This product has not been tested with latex NG or PEG tubes and therefore should not be used with tubes made from latex. These measures will help protect the environment. Metoclopramide may cause drowsiness, dizziness, dyskinesia and dystonias which can affect the vision and also interfere with the ability to drive and operate machinery. Cardiac Disorders There have been reports of serious cardiovascular undesirable effects including cases of circulatory collapse, severe bradycardia, cardiac arrest and QT prolongation following administration of metoclopramide by injection, particularly via the intravenous route see section 4. With Gonadorelin test, concurrent use with metoclopramide may blunt the response to gonaderelin by increasing serum prolactin concentrations. Shock, Syncope after injectable use, Acute hypertension in patients with phaeochromocytoma see section 4. What is a Patient Information Leaflet and why is it useful?

Uploader: Dir
Date Added: 12 May 2007
File Size: 29.91 Mb
Operating Systems: Windows NT/2000/XP/2003/2003/7/8/10 MacOS 10/X
Downloads: 67484
Price: Free* [*Free Regsitration Required]

The recommended single dose is 10 mg, repeated up to three times daily.

The exact mechanism of action is unknown; it is believed that metoclopramide inhibits gastric smooth muscle relaxation produced by dopamine thus enhancing cholinergic responses of the gastrointestinal smooth muscles. The maximum recommended treatment duration is 5 days. Metoclopramide has a half life of four to six hours. Taking this medicine This medicine contains 5 milligram mg of metoclopramide hydrochloride in each 5 millilitre ml of solution. Low density polyethylene 6.

Do not take a double dose two doses at the same time to make up for a forgotten dose.


These may be signs of metoclolramide condition called neuroleptic malignant syndrome changes in heart beat, which may be shown on an ECG test fainting, shock severe decrease of heart pressure or cardiac arrest particularly when metoclopramide is given by injection allergic reaction which may be severe particularly when metoclopramide is given by injection a sudden rise in blood pressure in patients with a tumour of the adrenal gland phaeochromocytoma disturbance of vision shortness of breath.

Name of the medicinal product 2. Methaemoglobinemia Methaemoglobinemia which could be related to NADH cytochrome b5 reductase deficiency syrinbe been reported. Active ingredient metoclopramide hydrochloride.

A 10ml oral syringe with markings at every 1ml and intermediate marks at every 0. By continuing to browse the site you are agreeing to our policy on the use of cookies. This site uses cookies.

Finally, pull the piston down to the graduation mark corresponding to the quantity in millilitres ml prescribed by your doctor Figure 4C. Finally, pull the piston down to the graduation mark corresponding to the quantity in millilitres ml prescribed by your doctor Figure 4C.

Metoclopramide may cause elevation of serum prolactin levels. Do not use the oral syringe provided in the pack. Please tell metoclopdamide doctor or pharmacist if you are taking or have recently taken any other medicines.

For further instructions see section 6. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at www.

Metoclopramide Hydrochloride 5mg/5ml Oral Solution

As an anti-emetic; the dopamine antagonist action raises the threshold of activity in the chemoreceptor trigger zone and decreases the input from afferent visceral nerves.


Not known to be harmful. To bookmark a medicine you must sign up and log in. A large amount of data on pregnant women more than exposed outcomes indicates neither malformative toxicity nor foetotoxicity. Possible side effects 5. All indications adult patients The recommended single dose is 10 mg, repeated up to three times daily. Atovaquone Metoclopramide may reduce plasma concentrations of atovaquone. Respiratory, thoracic and mediastinal disorders.


Turn the bottle the right way up Figure 5A. Cardiac arrest, occurring shortly after injectable use, and which can be subsequent to bradycardia see section 4. To help minimise the risk of potentially serious neurological adverse effects, the following restrictions to indications, dose, and duration of use have been made: Metoclopramide should be discontinued immediately in the event of symptoms of neuroleptic malignant syndrome and appropriate treatment should be initiated.

This allergy may happen some time after starting the medicine sorbitol a type of sugar. The early warning signs are unusually fast heart beats and sweating.